Anacetrapib Raised HDL, Lowered LDL
The cholesteryl ester transfer protein (CETP) inhibitor
anacetrapib (Merck and Co., Whitehouse Station, New
Jersey) dramatically raised high-density lipoprotein (HDL)
cholesterol and lowered low-density lipoprotein (LDL)
cholesterol, according to a study in the New England
Journal of Medicine.1
Christopher P. Cannon, ...